Nywerhede
Showing 101–110 van 134 results
-
Physical Examination Market in China
In China, following a significant (17.6%) rise in 2019, physical examination market in terms of revenue declined dramatically (-11.2%), reaching 30 billion USD in 2020, volgens StrategyHelix.
-
Oral Health Services Market in China
In China, following a significant (11.9%) rise in 2019, oral health services market in terms of revenue declined dramatically (-16.7%), reaching 17,277 million USD in 2020, volgens StrategyHelix.
-
Ophthalmic Diagnosis Market in China
The ophthalmic diagnosis market in China was around 127 miljoen in 2019, bereik 134 miljoen in 2020 (an increase of 5.1% jaar-tot-jaar), volgens StrategyHelix’ analysis.
-
Ophthalmic Medical Market in China
The ophthalmic medical market in China was around 18,184 million USD in 2019, bereik 20,464 million USD in 2020 (an increase of 12.5% jaar-tot-jaar), volgens StrategyHelix’ analysis.
-
Peptide Market in China
A statistic by StrategyHelix indicates that the peptide market in China is anticipated to expand positively at a CAGR of 14.9% gedurende die voorspellingsperiode (2021-2027).
-
Minoxidil Market in China
The minoxidil market in China is projected to expand by a CAGR of 12% van 2021 through 2027.
-
Smart Healthcare Market in China
According to a statistic by StrategyHelix, the smart healthcare market in China is set to increase by US$ 5,744 miljoen tydens 2021-2027, growing at a CAGR of 12.2% gedurende die voorspellingsperiode.
-
Global Pharmaceutical R&D Spending Market
The global pharmaceutical R&D spending market is anticipated to expand positively at a CAGR of 6.8% gedurende die voorspellingsperiode (2021-2027), volgens StrategyHelix.
-
Global CRO (Contract Research Organization) Market
A statistic by StrategyHelix indicates that the global CRO (contract research organization) market is expected to increase at a CAGR of 9.9% till 2027.
-
CRO (Contract Research Organization) Mark in China
A statistic by StrategyHelix indicates that the CRO (contract research organization) mark in China sal na verwagting met VS$ toeneem 23,328 miljoen van 2021 aan 2027, 'n CAGR van 21.9% gedurende die voorspellingsperiode.